Harold Edward Fleming - 10 Oct 2024 Form 4 Insider Report for Upstream Bio, Inc. (UPB)

Role
Director
Signature
/s/ Michael Gray, Attorney-in-Fact
Issuer symbol
UPB
Transactions as of
10 Oct 2024
Transactions value $
$0
Form type
4
Filing time
15 Oct 2024, 16:15:08 UTC
Previous filing
31 May 2024
Next filing
06 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UPB Stock Option (Right to Buy) Award $0 +17,096 $0 17,096 10 Oct 2024 Common Stock 17,096 $17 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest upon the earlier of (i) October 10, 2025 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
F2 Mr. Fleming has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Issuer's board of directors. As such, Mr. Fleming disclaims beneficial ownership of, and all right, title and interest in, the option and the shares issuable upon exercise thereof.